WHAT IS PRECISION THERAPY?
A More Personalized Approach to Cancer Treatment
Precision therapy focuses on the genetic and molecular changes that drive a cancer’s growth. By identifying the abnormal signal behind a tumor, care can be better aligned to the biology of that specific cancer.
At Taylor Cancer Research Center, precision therapy is an important part of how we think about research-driven cancer care. This approach helps define treatment opportunities based on what is happening within a patient’s individual cancer, rather than treating every cancer the same way.
Precision Therapy Starts with Understanding What Is Driving a Cancer
Instead of treating all cancers the same way, precision therapy looks for the molecular signal or mutation that is helping the cancer grow. Once that signal is identified, treatment is selected to more specifically target the cancer-driving defect.
This more personalized approach also opens the door to clinical trial opportunities, especially when a patient’s tumor contains a specific molecular feature that matches an investigational therapy.
How Precision Therapy Works
A comprehensive gene profile of blood or cancer tissue can help identify the signal pathway responsible for cancer survival. Defects, or mutations, in genes along these pathways can change normal cell function into cancer cell function. Taylor Cancer Research Center describes assessment of comprehensive gene profiling as a routine process in identifying these targets.
Based on new developments in molecular biology, this information helps identify precision therapies designed to block the cancer-driving gene. This allows treatment to be more closely aligned with the biology of the cancer while minimizing effects on normal cells.
A Simpler Way to Think About It
One way to understand precision therapy is to think about finding the exact part of an engine that is not working properly. Instead of replacing the whole engine, you identify the specific defective part and focus on fixing that one issue. In cancer treatment, precision therapy follows a similar idea by identifying the abnormal signal that is driving the cancer and targeting that signal more directly.
Normal signal pathway → abnormal molecular signal → targeted therapy opportunity
Step 1
Gene profile testing
Step 2
Identify the signal
Step 3
Match treatment or trial
Following Response Over Time
Response to precision therapy is followed through sequential molecular testing of blood, helping clinicians assess treatment effectiveness and monitor response more closely.
This ability to monitor change is one of the ways precision therapy supports a more individualized and adaptive approach to care.
How Precision Therapy Connects to Clinical Trials
At Taylor Cancer Research Center, clinical trial opportunities involve precision therapies used alone or in combination with other therapies. Comprehensive gene profiling helps identify whether a patient’s cancer has the molecular signal needed to qualify for a specific trial.
This information helps determine whether a patient is a fit for a clinical trial designed around a specific molecular signal.
Personalized Treatment Begins with Better Understanding
Precision therapy helps bring a more personalized approach to cancer care by focusing on the genetic and molecular changes that make each cancer unique. At TCRC, that approach supports both treatment planning and access to clinical trial opportunities.